Results 11 to 20 of about 25,643 (173)
Enalapril: Synthesis and properties [PDF]
Hemijska Industrija, 2004 Enalapril was originally synthesized by Merck Sharp and Dohme and is an angiotensin converting enzyme inhibitor. Thus, enalapril is used in the treatment of mild to severe hypertension. Enalapril is chemically (S)-1-[N-[1-(et-hoxycarbonyl)-3-phenylpropyl]
Mijin Dušan Ž. +2 more
doaj +2 more sources
A Cohort Study on Incidence and Factors Associated With Adverse Drug Reactions of Enalapril in Lusaka, Zambia. [PDF]
Pharmacol Res PerspectABSTRACT Angiotensin‐converting enzyme inhibitors (ACEIs) are widely prescribed but are associated with adverse drug reactions (ADR), including angioedema, which is typically reported in 0.1%–0.7%. Data from sub‐Saharan Africa are limited. This study aimed to estimate the incidence and risk factors of enalapril‐associated ADRs in a Zambian cohort, with
Yikon'a N +5 more
europepmc +2 more sources
Effect of moxifloxacin on pharmacokinetics of enalapril in rats [PDF]
E3S Web of Conferences, 2021 The purpose of this study was to investigate the effect of moxifloxacin on the pharmacokinetics of enalapril. Single administration experiment: 12 Wistar rats were randomly divided into two groups on average.
Jing Zhao, Jiarui Peng, Yinxia Zhang
doaj +2 more sources
Arquivos Brasileiros de Cardiologia, 2000 OBJECTIVE: To compare the regression of left ventricular hypertrophy in patients with moderate hypertension treated with enalapril, losartan or a combination of the two drugs at lower doses.
Antônio Carlos Avanza Jr +2 more
doaj +2 more sources
Higher persistence with valsartan compared with enalapril in daily practice
Vascular Health and Risk Management, 2008 Satu J Siiskonen1, Nancy S Breekveldt-Postma1, Gábor Vincze2, Zeba M Khan3, Joëlle A Erkens1, Ron MC Herings11PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis ...
Satu J Siiskonen +5 more
doaj +1 more source
Very low enalapril and enalaprilat exposure via human milk: a case report from the ConcePTION project [PDF]
Frontiers in PharmacologyIntroductionOngoing maternal and clinical hesitancy in breastfeeding-related shared decision-making is driven by limited safety data on maternal pharmacotherapy.
Emily Jacobs +21 more
doaj +2 more sources
Safety and Efficacy of Enalapril Combined with Metoprolol in Patients of Hypertension Complicated with Coronary Heart Disease: A Randomised Clinical Trial [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Enalapril, which inhibits Angiotensin-Converting Enzyme (ACE), is a commonly used drug for the treatment of hypertension. Metoprolol, a β-blocker, is widely prescribed for patients with cardiac diseases.
Ping Wang +3 more
doaj +1 more source
Evaluation of the Hepatotoxicity Induced by Captopril and Enalapril in Rat Liver: A Comparative Study [PDF]
Basrah Journal of Veterinary Research, 2023 The aim of this study was to look into the toxicity of captopril and enalapril in high doses in the liver. The animals in this experiment were divided into five groups of ten each, with the first group serving as a control group, receiving only distilled
Mohammed Ibrahim +2 more
doaj +1 more source
Enalapril in patients after mitral valve replacement [PDF]
Кардиоваскулярная терапия и профилактика, 2007 Aim. To assess enalapril effectiveness in myocardial remodeling correction among patients after mitral valve replacement. Material and methods. In total, 54 patients (mean age 46,3±7,6 years) with isolated or prevalent mitral valve stenosis were examined.
O. L. Barbarash +4 more
doaj +1 more source
BMC Medicine, 2022 Background For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compared with ...
Tiantian Zhang +11 more
doaj +1 more source